Stevens First Principles Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$12K Hold
161
0.01% 118
2019
Q1
$13K Hold
161
0.01% 122
2018
Q4
$15K Hold
161
0.01% 119
2018
Q3
$15K Buy
161
+35
+28% +$3.32K 0.01% 128
2018
Q2
$12K Buy
126
+31
+33% +$3.03K 0.01% 127
2018
Q1
$9K Hold
95
0.01% 131
2017
Q4
$9K Hold
95
﹤0.01% 156
2017
Q3
$8K Hold
95
﹤0.01% 151
2017
Q2
$7K Hold
95
﹤0.01% 149
2017
Q1
$6K Hold
95
﹤0.01% 143
2016
Q4
$6K Hold
95
﹤0.01% 148
2016
Q3
$6K Hold
95
﹤0.01% 134
2016
Q2
$6K Hold
95
﹤0.01% 124
2016
Q1
$5K Buy
+95
New +$5.29K ﹤0.01% 127
2015
Q1
Sell
-1,000
Closed -$65K 209
2014
Q4
$65K Buy
+1,000
New +$63K 0.04% 125

Other funds holding ABBV

Stevens First Principles Investment Advisors's ABBV Position: Q2 2019 in Review

Stevens First Principles Investment Advisors held its AbbVie (ABBV) position steady in Q2 2019 at 161 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #118.

Stevens First Principles Investment Advisors first reported a position in ABBV in Q4 2014 and has held it in 15 quarters since. The position peaked at $65K in Q4 2014. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Stevens First Principles Investment Advisors held 161 shares of AbbVie worth $12K as of Q2 2019.
  • Stevens First Principles Investment Advisors left its AbbVie share count unchanged in Q2 2019.
  • AbbVie made up 0.01% of Stevens First Principles Investment Advisors's portfolio in Q2 2019, its #118 holding.
  • Stevens First Principles Investment Advisors first reported a position in AbbVie in Q4 2014 and has held it in 15 quarters since.
  • Stevens First Principles Investment Advisors's AbbVie position peaked at $65K in Q4 2014.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.